Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

B Barlogie; R Desikan; P Eddlemon; T Spencer; J Zeldis; N Munshi; A Badros; M Zangari; E Anaissie; J Epstein

doi:10.1182/blood.v98.2.492

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

Identifier:nobleid.org/w1/20260515/C6F95EB9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C6F95EB9.svg?ark=w1%2F20260515%2FC6F95EB9)](https://nobleid.org/work/w1/20260515/C6F95EB9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

Identifier:nobleid.org/w1/20260515/C6F95EB9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C6F95EB9.svg?ark=w1%2F20260515%2FC6F95EB9)](https://nobleid.org/work/w1/20260515/C6F95EB9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work